DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%

By Yahoo! Finance | Jul 11, 2024 at 02:54 PM EST

Individual investors hold significant control over DiaMedica Therapeutics, influencing management and governance decisions. Major shareholders include Thomas von Koch, Jan Stahlberg, and Richard Jacinto. Institutional ownership and analyst sentiments also play a role in the company's performance.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.